ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(15), P. 18400 - 18410
Published: April 5, 2024
Drug-resistant
bacterial
infection
and
biofilm
formation
are
the
key
inhibitors
of
wound
healing,
new
strategies
urgently
needed
to
address
these
issues.
In
this
study,
we
designed
a
pH-responsive
co-assembled
peptide
hydrogel
inhibit
Methicillin-resistant
Staphylococcus
aureus
(MRSA)
promote
healing.
We
synthesized
cationic
short
(Nap-FFKKK)
with
curcumin
at
pH
∼
7.8.
The
loaded
was
continuously
released
in
weak
acid
environment
(pH
5.5).
lysine-rich
inhibited
MRSA
via
electrostatic
interaction
negatively
charged
cell
surface
and,
thus,
provided
reinforcing
antibacterial
effect
curcumin.
vitro
experiments
showed
that
system
considerably
reduced
minimum
inhibitory
concentration
against
by
10-fold
promoted
healing
mouse
model
MRSA-infected
wounds.
This
study
provides
simple
promising
strategy
treat
drug-resistant
infections
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(10)
Published: Jan. 4, 2024
Abstract
Myocardial
infarction
(MI)
results
in
cardiomyocyte
necrosis
and
conductive
system
damage,
leading
to
sudden
cardiac
death
heart
failure.
Studies
have
shown
that
biomaterials
can
restore
conduction,
but
cannot
facilitate
tissue
regeneration.
This
study
aims
add
regenerative
capabilities
the
biomaterial
by
incorporating
human
endometrial
mesenchymal
stem
cell
(hEMSC)‐derived
exosomes
(hEMSC‐Exo)
into
poly‐pyrrole‐chitosan
(PPY‐CHI),
yield
an
injectable
hydrogel
effectively
treat
MI.
In
vitro,
PPY‐CHI/hEMSC‐Exo,
compared
untreated
controls,
PPY‐CHI,
or
hEMSC‐Exo
alone,
alleviates
H
2
O
‐induced
apoptosis
promotes
tubule
formation,
while
vivo,
PPY‐CHI/hEMSC‐Exo
improves
post‐MI
functioning,
along
with
counteracting
against
ventricular
remodeling
fibrosis.
All
these
activities
are
facilitated
via
increased
epidermal
growth
factor
(EGF)/phosphoinositide
3‐kinase
(PI3K)/AKT
signaling.
Furthermore,
properties
of
able
resynchronize
electrical
transmission
alleviate
arrythmia.
Overall,
synergistically
combines
PPY‐CHI
improve
promoting
angiogenesis
inhibiting
apoptosis,
as
well
resynchronizing
ultimately
enable
more
effective
MI
treatment.
Therefore,
a
provides
dual
benefits
terms
maintaining
conductivity,
facilitating
long‐term
exosome
release
sustained
application
their
beneficial
effects.
Periodontology 2000,
Journal Year:
2024,
Volume and Issue:
94(1), P. 257 - 414
Published: Feb. 1, 2024
Abstract
Exosomes
are
the
smallest
subset
of
extracellular
signaling
vesicles
secreted
by
most
cells
with
ability
to
communicate
other
tissues
and
cell
types
over
long
distances.
Their
use
in
regenerative
medicine
has
gained
tremendous
momentum
recently
due
their
be
utilized
as
therapeutic
options
for
a
wide
array
diseases/conditions.
Over
5000
publications
currently
being
published
yearly
on
this
topic,
number
is
only
expected
dramatically
increase
novel
strategies
continue
developed.
Today
exosomes
have
been
applied
numerous
contexts
including
neurodegenerative
disorders
(Alzheimer's
disease,
central
nervous
system,
depression,
multiple
sclerosis,
Parkinson's
post‐traumatic
stress
disorders,
traumatic
brain
injury,
peripheral
nerve
injury),
damaged
organs
(heart,
kidney,
liver,
stroke,
myocardial
infarctions,
ovaries),
degenerative
processes
(atherosclerosis,
diabetes,
hematology
musculoskeletal
degeneration,
osteoradionecrosis,
respiratory
disease),
infectious
diseases
(COVID‐19,
hepatitis),
procedures
(antiaging,
bone
regeneration,
cartilage/joint
osteoarthritis,
cutaneous
wounds,
dental
dermatology/skin
erectile
dysfunction,
hair
regrowth,
intervertebral
disc
repair,
spinal
cord
vascular
regeneration),
cancer
therapy
(breast,
colorectal,
gastric
osteosarcomas),
immune
function
(allergy,
autoimmune
regulation,
inflammatory
diseases,
lupus,
rheumatoid
arthritis).
This
scoping
review
first
its
kind
aimed
at
summarizing
extensive
potential
broad
range
disorders.
Stem Cell Research & Therapy,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: Nov. 22, 2021
Stem
cell
therapy
is
widely
recognized
as
a
promising
strategy
for
exerting
therapeutic
effects
after
injury
in
degenerative
diseases.
However,
limitations
such
low
retention
and
survival
rates
transplantation
exist
clinical
applications.
In
recent
years,
emerging
biomaterials
that
provide
supportable
cellular
microenvironment
transplanted
cells
have
optimized
the
efficacy
of
stem
injured
tissues
or
organs.
Advances
engineered
are
revolutionizing
our
understanding
cell-based
therapies
by
co-transplanting
with
synthetic
tissue-derived
biomaterials,
which
offer
scaffold
propose
an
unprecedented
opportunity
to
further
employ
significant
influences
tissue
repair
regeneration.
Stem Cell Research & Therapy,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: March 20, 2021
Abstract
Background
The
senescence
of
dermal
fibroblasts
(DFLs)
leads
to
an
imbalance
in
the
synthesis
and
degradation
extracellular
matrix
(ECM)
proteins,
presenting
so-called
senescence-associated
secretory
phenotype
(SASP),
which
ultimately
skin
aging.
Recently,
mesenchymal
stem
cell
(MSC)-derived
vesicles
(EVs)
have
been
recognized
as
a
promising
cell-free
therapy
for
degenerative
diseases,
opens
new
avenue
aging
treatment.
Methods
In
this
study,
we
utilized
chitosan
(CS)
hydrogel
effective
loading
sustained
release
EVs.
vitro,
explored
rejuvenation
effects
CS
hydrogel-incorporated
EVs
(CS-EVs)
on
replicative
DFLs
through
series
experiments
such
β-galactosidase
(SA-β-gal)
staining,
RT-PCR,
Western
blot
analysis.
Besides,
employed
local
multi-site
subcutaneous
injection
treat
naturally
aged
mice
with
CS-EVs
DiI
fluorescent
dye
was
used
label
achieve
vivo
real-time
tracking.
Results
can
significantly
improve
biological
functions
senescent
fibroblasts,
including
promoting
their
proliferation,
enhancing
ECM
inhibiting
overexpression
metalloproteinases
(MMPs).
Moreover,
could
prolong
increase
retention
vivo.
After
treatment,
tissues
showed
state,
manifested
explicitly
enhanced
expression
collagen,
decreased
SASP-related
factors,
restoration
tissue
structures.
Conclusions
hydrogel-encapsulated
delay
processes
by
ameliorating
function
DFLs.
Our
results
also
highlight
potential
novel
therapeutic
strategy
improving
rejuvenation.
Advanced Functional Materials,
Journal Year:
2023,
Volume and Issue:
33(49)
Published: Aug. 2, 2023
Abstract
Ischemic
stroke
is
a
major
cause
of
death
and
disability
worldwide.
The
poor
drug
delivery
to
cerebral
ischemic
regions
remains
challenging
issue
for
treatment.
Curcumin
(Cur)
edaravone
(EDV)
show
remarkable
therapeutic
effects
on
stroke.
However,
the
short
half‐life
aqueous
solubility
limit
their
application
long‐term
effective
neuroprotection.
Cur
EDV
with
well‐studied
hydrogelator
Nap‐Phe‐Phe‐Tyr‐OH
(NapFFY)
co‐assembled
prepare
novel
supramolecular
peptide
hydrogel
EDV/Cur/NapFFY
,
which
can
improve
bioavailability
transport
hydrophobic
drugs
sites
precisely
by
local
administration.
In
vitro
release
test
demonstrate
that
co‐assembly
NapFFY
enables
continuous
about
two
weeks.
Animal
studies
found
effectively
promote
brain
plasticity
enhance
functional
recovery
photothrombotic
mouse
model.
Overall,
work
reveales
great
potential
system
in
promoting
repair
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(2), P. 663 - 663
Published: Feb. 16, 2023
In
recent
years,
extracellular
vesicles
(EVs)
have
emerged
as
promising
biomarkers,
cell-free
therapeutic
agents,
and
drug
delivery
carriers.
Despite
their
great
clinical
potential,
poor
yield
unscalable
production
of
EVs
remain
significant
challenges.
When
using
3D
culture
methods,
such
scaffolds
bioreactors,
large
numbers
cells
can
be
expanded
the
cell
environment
manipulated
to
control
phenotype.
This
has
been
employed
successfully
increase
well
enhance
effects.
The
physiological
relevance
cultures,
spheroids,
also
provided
a
strategy
for
understanding
role
in
pathogenesis
several
diseases
evaluate
tools
deliver
drugs.
Additionally,
methods
encapsulate
achieve
more
sustained
effects
prevent
premature
clearance
enable
localised
concentrated
exosome
dosage.
review
highlights
opportunities
drawbacks
different
use
EV
research.